Recombinant Human EphA8 Fc Chimera Protein, CF

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

EphA8, also known as Hek3 and Eek, is a 120 kDa glycosylated member of the Eph family of transmembrane receptor tyrosine kinases (1, 2). The A and B classes of Eph proteins are distinguished by Ephrin ligand binding preference but have a common structural organization. EphA4 binds and is activated by class A Ephrins but not class B Ephrins (3, 4). Eph-Ephrin interactions are widely involved in the regulation of cell migration, tissue morphogenesis, and cancer progression. The 512 amino acid (aa) extracellular domain (ECD) of human EphA8 contains an N-terminal Ephrin binding region, a cysteine-rich region, and two fibronectin type III domains (FnIII). The 442 aa cytoplasmic domain contains the tyrosine kinase domain and a sterile alpha motif (SAM) (5). Within the ECD, human EphA8 shares 97% aa sequence identity with mouse and rat EphA8. EphA8 is expressed in neurons in the mesencephalon of the developing brain, particularly in the rostral tectum and the superior colliculus (6-8). It is enriched at the tips of neurite processes and plays a role in projection of superior colliculus axons through the posterior commissure (7, 9). Its expression enhances neurite extension by means of a mechanism that does not require catalytic activity of the tyrosine kinase domain (10). Ephrin-mediated activation of the EphA8 kinase induces phosphorylation of tyrosine residues in the cytoplasmic domain, leading to association with signaling and scaffolding proteins and inhibition of cell-cell adhesion (4, 9, 11). Ligand binding can also promote the Integrin-mediated cellular adhesion to Fibronectin (12). This function, like the enhancement of neurite extension, does not require activation of the kinase domain (12).

We have publications tested in 1 confirmed species: N/A.

We have publications tested in 1 application: ELISA Capture.

Showing Publication 1 - 1 of 1.

Publication using 6828-A8	Applications	Species
JH Cha, LC Chan, YN Wang, YY Chu, CH Wang, HH Lee, W Xia, WC Shyu, SP Liu, J Yao, CW Chang, FR Cheng, J Liu, SO Lim, JL Hsu, WH Yang, GN Hortobagyi, C Lin, L Yang, D Yu, LB Jeng, MC Hung Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer The Journal of Biological Chemistry, 2022-03-10;0(0):101817. 2022-03-10 [PMID: 35278434] (ELISA Capture, N/A)	ELISA Capture	N/A

Array 6828-A8

• EphA8 Antibodies
• EphA8 Protein
• EphA8 Proteins and Enzyme